SOM Biotech will attend the 4th International Meeting of People affected by ALS (Amyotrophic Lateral Sclerosis). Burgos (Spain), 6th-11th April 2014. SOM Biotech will take part in the 4th International Meeting of People with ALS and Researchers organized jointly by the Spanish Ministry of Health and the Association of People Affected by ELA. The sessions …
SOM Biotech attended Bio-Europe Spring 2014 in Turin. 2,000 high-level executives from pharma, biotech, venture capital firms, and service companies were present at this event and over 11,000 partnering meetings took place in just three days. SOM Biotech was able to meet several delegates from medium-big pharma companies. ( http://www.ebdgroup.com/bes/index.php)
SOM Biotech is the winner company of the EntrepreneurXXI prize, life science section. This event is granted by “La Caixa” and the Spanish Ministry of Industry. Further information in spanish
SOM Biotech will have the chance to meet Medium-Big Pharma delegates during next international partnering BioEurope 2013 in Vienna. Important deals will be achieved. ( http://www.ebdgroup.com/bioeurope/index.php)
SOM Biotech is one of the finalist companies of the Entrepreneur XXI prize among more than 600 participants. Prize granted by “La Caixa” and ENISA. ( http://premios2013.emprendedorxxi.es/) (Winners 2013)
SOM Biotech, has been identified as one of the best opportunities to invest in start-up biopharmaceuticals companies in Catalonia. Link: http://www.neweuropeaneconomy.com/home-mainmenu-51/fdi-mainmenu-59/514-adding-value-to-existing-drugs
A recent Thomson Reuters report indicates that drug repositioning is expected to generate up to $20Billion in annual sales during 2012, thus opening up a new source of revenue to large, medium and small Pharma companies.
SOM0226, a reprofiled drug for the treatment of TTR amyloidosis, has been presented at the XIIIth International Symposium on Amyloidosis in Groningen, The Netherlands. The product has been recognized as one of the most promising in-coming therapies by the scientific expert community in the field.